Inotiv, Inc.

Inotiv provides nonclinical and analytical services supporting drug discovery and development for pharmaceutical and medical device companies. The company operates across two primary business segments: Discovery and Safety Assessment (DSA), which manufactures scientific instruments and software for life sciences research under the BASi brand, and Research Models and Services (RMS), which produces research models, laboratory diets, bedding materials, and bioproducts. These offerings serve pharmaceutical companies, universities, government research centers, and medical research institutions.

The DSA segment focuses on instrumentation and analytical tools used in preclinical drug development, while RMS generates revenue through the commercial supply of research animals and related consumables essential to laboratory operations. The company maintains operations in the United States, the Netherlands, and other international markets. With approximately 1,945 full-time employees, Inotiv operates as a mid-sized contract research organization. The company was incorporated in 1974 as Bioanalytical Systems, Inc. and adopted its current name in March 2021, maintaining its headquarters in West Lafayette, Indiana.